Compared with the healthy controls, the percentage of circulating Th22 cells in total peripheral CD3+CD8- lymphocytes of RCC patients was significantly increased (1.97 ± 0.32% vs. 0.75 ± 0.05%, ***P<0.001; Fig. 2A). Here, CD8A is linked to renal cell carcinoma.